Intuitive Surgical Aktie 1631646 / US46120E6023
504.07
USD
-3.46
USD
-0.68 %
30.01.2026
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Intuitive Surgical Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2025 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2024 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2023 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2022 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2021 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2020 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2019 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2018 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2017 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2016 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
Gewinn je Aktie- Intuitive Surgical
| 7.9 25 | 6.4 24 | 5.0 23 | 3.6 22 | 4.7 21 | 2.9 20 | 3.8 19 |
Umsatz je Aktie- Intuitive Surgical
| 27.7 25 | 23.1 24 | 19.9 23 | 17.2 22 | 15.6 21 | 12.1 20 | 12.5 19 |
KGV- Intuitive Surgical
| 72.0 25 | 81.4 24 | 67.1 23 | 72.6 22 | 77.1 21 | 92.8 20 | 51.2 19 |
Intuitive Surgical Inc: Die Aktie (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | 7.87 | 6.42 | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 |
| Gewinn je Aktie (unverwässert) | 8.00 | 6.54 | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 |
| Gewinn je Aktie (verwässert) | 7.87 | 6.42 | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 |
| Dividende je Aktie | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Veränderung Dividende je Aktie in % | - | - | - | - | - | - | - |
| Gesamtdividendenausschüttung in Mio. | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intuitive Surgical Inc: Unternehmenskennzahlen (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 27.75 | 23.07 | 19.93 | 17.19 | 15.61 | 12.08 | 12.49 |
| KGV (Jahresendkurs, Gewinn unverwässert) | 71.96 | 81.35 | 67.06 | 72.64 | 77.10 | 92.79 | 51.22 |
| KGV (Jahresendkurs, Gewinn verwässert) | 71.96 | 81.35 | 67.06 | 72.64 | 77.10 | 92.79 | 51.22 |
| Dividendenrendite Jahresende in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Eigenkapitalquote in % | 87.70 | 87.74 | 86.30 | 85.65 | 88.17 | 87.38 | 85.12 |
| Fremdkapitalquote in % | - | 12.26 | 13.70 | 14.35 | 11.83 | 12.62 | 14.88 |
Intuitive Surgical Inc: GuV (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 10’064.70 | 8’352.10 | 7’124.10 | 6’222.20 | 5’710.10 | 4’358.40 | 4’478.50 |
| Umsatzveränderung in % | 20.51 | 17.24 | 14.49 | 8.97 | 31.01 | -2.68 | 20.25 |
| Bruttoergebnis vom Umsatz | 6’655.50 | 5’634.20 | 4’729.50 | 4’187.40 | 3’940.10 | 2’838.50 | 3’098.70 |
| Bruttoergebnisveränderung in % | 18.13 | 19.13 | 12.95 | 6.28 | 38.81 | -8.40 | 19.36 |
| Operatives Ergebnis | 2’945.50 | 2’348.90 | 1’766.80 | 1’577.10 | 1’821.00 | 1’048.60 | 1’375.00 |
| Veränderung Operatives Ergebnis in % | 25.40 | 32.95 | 12.03 | -13.39 | 73.66 | -23.74 | 10.48 |
| Ergebnis vor Steuern | 3’311.40 | 2’673.80 | 1’958.90 | 1’606.80 | 1’890.30 | 1’207.00 | 1’502.20 |
| Veränderung Ergebnis vor Steuern in % | 23.85 | 36.49 | 21.91 | -15.00 | 56.61 | -19.65 | 17.41 |
| Ergebnis nach Steuer | 2’856.00 | 2’322.60 | 1’798.00 | 1’322.30 | 1’704.60 | 1’060.60 | 1’379.30 |
| Veränderung Ergebnis nach Steuer in % | 22.97 | 29.18 | 35.98 | -22.43 | 60.72 | -23.11 | 22.29 |
Intuitive Surgical Inc: Bilanz (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | - | 2’309 | 2’126 | 1’861 | 1’604 | 1’410 | 1’449 |
| Langzeit Gesamtverbindlichk. je Aktie | - | 1.58 | 1.33 | 1.26 | 1.27 | 1.26 | 1.20 |
| Eigenkapital | 17’942 | 16’530 | 13’397 | 11’113 | 11’952 | 9’759 | 8’285 |
| Veränderung Eigenkapital in % | 9.18 | 23.49 | 20.52 | -7.22 | 22.29 | 17.76 | 23.73 |
| Bilanzsumme | 20’459 | 18’839 | 15’524 | 12’974 | 13’555 | 11’169 | 9’733 |
| Veränderung Bilanzsumme in % | 8.60 | 21.35 | 19.65 | -4.29 | 21.36 | 14.75 | 24.04 |
Intuitive Surgical Inc: Sonstige Angaben (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 8.00 | 6.54 | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 22.38 | 27.72 | 37.72 | -22.34 | 58.42 | -24.16 | 20.49 |
| Gewinn je Aktie (verwässert) | 7.87 | 6.42 | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 |
| Veränderung Gewinn je Aktie (verwässert) in % | 22.66 | 27.53 | 37.72 | -21.61 | 58.56 | -23.62 | 21.57 |
| Anzahl Mitarbeiter | - | 15’638 | 13’676 | 12’120 | 9’793 | 8’081 | 7’326 |
| Veränderung Anzahl Mitarbeiter in % | - | 14.35 | 12.84 | 23.76 | 21.19 | 10.31 | 32.55 |
Intuitive Surgical Inc Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Intuitive Surgical Inc | Quartalszahlen | 21.04.2026 |
| Intuitive Surgical Inc | Quartalszahlen | 16.07.2026 |
| Intuitive Surgical Inc | Quartalszahlen | 20.10.2026 |
| Intuitive Surgical Inc | Quartalszahlen | 26.01.2027 |
Intuitive Surgical Inc vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q4 2025 Earnings Release | 22.01.2026 |
| Quartalszahlen | Q3 2025 Earnings Release | 21.10.2025 |
| Quartalszahlen | Q2 2025 Earnings Release | 22.07.2025 |
| Hauptversammlung | Annual General Meeting | 01.05.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 22.04.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 23.01.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 17.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 18.07.2024 |
| Hauptversammlung | Annual General Meeting | 25.04.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 18.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 23.01.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 19.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 20.07.2023 |
| Hauptversammlung | Annual General Meeting | 27.04.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 18.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 24.01.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 18.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 21.07.2022 |
| Hauptversammlung | Annual General Meeting | 28.04.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 21.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 20.01.2022 |
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 7’326 | 8’081 | 9’793 | 12’120 | 13’676 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.61 | 0.54 | 0.58 | 0.51 | 0.52 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 4’663 | 6’626 | 5’845 | 6’253 | 7’888 |
| Summe Anlagevermögen | 5’071 | 4’543 | 7’710 | 6’721 | 7’636 |
| Summe Aktiva | 9’733 | 11’169 | 13’555 | 12’974 | 15’524 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1’449 | 1’410 | 1’604 | 1’861 | 2’126 |
| Summe Eigenkapital | 8’285 | 9’759 | 11’952 | 11’113 | 13’397 |
| Summe Passiva | 9’733 | 11’169 | 13’555 | 12’974 | 15’524 |
Adresse
| 1020 Kifer Road, 94086-5304 Sunnyvale | |
| Telefon | +1 (408) 523-2100 |
| URL | http://www.intuitive.com |
Management
|
Amal M. Johnson
Independent Director |
|
Amy L. Ladd
Independent Director |
|
Brian E. Miller
Head-Digital & AI Strategy |
|
Calvin Darling
Senior Director-Finance & Investor Relations |
|
Christopher R. Carlson
EVP-Research & Corporate Development |
|
Craig H. Barratt
Lead Independent Director |
|
Darla Hutton
VP-Asia Commercial Operations & Marketing |
|
David J. Rosa
Chief Executive Officer & Director |
|
Fredrik C. Widman
Principal Accounting Officer, VP & Controller |
|
Gary H. Loeb
Executive VP, Chief Legal & Compliance Officer |
|
Gary S. Guthart
Executive Chairman |
|
Glenn Vavoso
Senior Vice President & President-Asia Pacific |
|
Henry L. Charlton
EVP, Chief Commercial & Marketing Officer |
|
Ian Purdy
Chief Quality Officer & Senior Vice President |
|
Jami K. Dover Nachtsheim
Independent Director |
|
Jamie E. Samath
Chief Financial Officer & Executive Vice President |
|
Joseph C. Beery
Independent Director |
|
Kara Andersen Reiter
Senior VP-Litigation, Privacy & Employment Law |
|
Keith R. Leonard
Independent Director |
|
Lewis Chew
Independent Director |
|
Mark J. Rubash
Independent Director |
|
Mark P. Brosius
SVP, Chief Manufacturing & Supply Chain Officer |
|
Monica P. Reed
Independent Director |
|
Myriam J. Curet
Chief Medical Officer & Executive Vice President |
|
Patricia L. Wadors
Chief Human Resources Officer |
|
Sreelakshmi Kolli
Independent Director |